Trial Profile
Comparison of effects of agomelatine, desvenlafaxine and bupropion XR for treating anhedonia in patients with major depressive disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2015
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary) ; Bupropion (Primary) ; Desvenlafaxine (Primary)
- Indications Neurobehavioural manifestations
- Focus Therapeutic Use
- 23 Jan 2015 New trial record